{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:44:59Z","timestamp":1770831899208,"version":"3.50.1"},"reference-count":37,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2023.14154","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T12:02:05Z","timestamp":1700136125000},"source":"Crossref","is-referenced-by-count":3,"title":["Predictors of efficacy of anamorelin in patients with non\u2011small cell lung cancer and cachexia: A retrospective study"],"prefix":"10.3892","volume":"27","author":[{"given":"Yoshiko","family":"Ishioka","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Makiguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syunsuke","family":"Fujishima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Nunomura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Shiratori","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kageaki","family":"Taima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadatomo","family":"Tasaka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"key20231221130738_b1-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20231221130738_b2-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4065\/83.3.355","article-title":"Small cell lung cancer","volume":"83","author":"Sher","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"key20231221130738_b3-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"key20231221130738_b4-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"Ross","year":"2004","journal-title":"Br J Cancer"},{"key":"key20231221130738_b5-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"key20231221130738_b6-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20231221130738_b7-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO clinical practice guidelines","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"},{"key":"key20231221130738_b8-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of cancer cachexia: ASCO guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J Clin Oncol"},{"key":"key20231221130738_b9-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1517\/14656566.2015.1041500","article-title":"Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC","volume":"16","author":"Zhang","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"key20231221130738_b10-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2217\/fon.14.14","article-title":"Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome","volume":"10","author":"Currow","year":"2014","journal-title":"Future Oncol"},{"key":"key20231221130738_b11-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: Preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20231221130738_b12-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"518909","DOI":"10.1155\/2013\/518909","article-title":"Structure and physiological actions of ghrelin","volume":"2013","author":"Delporte","year":"2013","journal-title":"Scientifica"},{"key":"key20231221130738_b13-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"key20231221130738_b14-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key20231221130738_b15-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key20231221130738_b16-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: A multicenter, randomized, double-blind, crossover, pilot study","volume":"21","author":"Garcia","year":"2013","journal-title":"Support Care Cancer"},{"key":"key20231221130738_b17-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.12-5-594","article-title":"Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: Results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers","volume":"12","author":"Garcia","year":"2007","journal-title":"Oncologist"},{"key":"key20231221130738_b18-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","article-title":"Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers","volume":"19","author":"Garcia","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"key20231221130738_b19-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): Results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"key20231221130738_b20-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: A phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2017","journal-title":"Ann Oncol"},{"key":"key20231221130738_b21-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1007\/s00520-016-3144-z","article-title":"Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: Results of a randomized phase 2 trial","volume":"24","author":"Takayama","year":"2016","journal-title":"Support Care Cancer"},{"key":"key20231221130738_b22-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"key20231221130738_b23-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"key":"key20231221130738_b24-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: Facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20231221130738_b25-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key20231221130738_b26-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"key20231221130738_b27-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","article-title":"[Using the common terminology criteria for adverse events (CTCAE-version 5.0) to evaluate the severity of adverse events of anticancer therapies]","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"key20231221130738_b28-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/cam4.5206","article-title":"Efficacy and safety of anamorelin in patients with cancer cachexia: Post-hoc subgroup analyses of a placebo-controlled study","volume":"12","author":"Takayama","year":"2023","journal-title":"Cancer Med"},{"key":"key20231221130738_b29-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jcsm.12391","article-title":"Affiliations expand is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study","volume":"10","author":"da Rocha","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20231221130738_b30-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.21873\/anticanres.14734","article-title":"Cancer cachexia reduces the efficacy of nivolumab treatment in patients with advanced gastric cancer","volume":"40","author":"Fujii","year":"2020","journal-title":"Anticancer Res"},{"key":"key20231221130738_b31-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"1950411","DOI":"10.1080\/2162402X.2021.1950411","article-title":"Affiliations expand impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: A retrospective study","volume":"10","author":"Morimoto","year":"2021","journal-title":"Oncoimmunology"},{"key":"key20231221130738_b32-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","article-title":"Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer","volume":"54","author":"Stene","year":"2015","journal-title":"Acta Oncol"},{"key":"key20231221130738_b33-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: Results from a placebo-controlled study","volume":"28","author":"Antoun","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20231221130738_b34-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"e000097","DOI":"10.1136\/bmjgast-2016-000097","article-title":"Cachexia in cancer: What is in the definition?","volume":"3","author":"Vanhoutte","year":"2016","journal-title":"BMJ Open Gastroenterol"},{"key":"key20231221130738_b35-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/jcsm.12201","article-title":"A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer","volume":"8","author":"Solheim","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20231221130738_b36-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/jcsm.12351","article-title":"Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer","volume":"10","author":"Naito","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20231221130738_b37-ol-27-1-14154","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12885-019-5762-6","article-title":"A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: The NEXTAC-TWO study protocol","volume":"19","author":"Miura","year":"2019","journal-title":"BMC Cancer"}],"updated-by":[{"DOI":"10.3892\/ol.2024.14360","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"record-id":"69275"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T11:18:17Z","timestamp":1703157497000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2023.14154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,11,16]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2023.14154","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"article-number":"22"}}